Nebenwirkungen · Keppra
Keppra 100 mg/ml oral solution · Abschnitt 4.8 · PDF-Seite 78–79
HOS-090862 · Präparat HOS-084117
78 Frequency category MedDRA SOC Very Common Uncommon Rare Very rare common Musculoskeletal Muscular Rhabdomyolysis and connective weakness, and blood tissue disorders myalgia creatine phosphokinase increased(3) Renal and Acute kidney urinary injury disorders General Asthenia/ disorders and fatigue administration site conditions Injury, Injury poisoning and procedural complications (1) See Description of selected adverse reactions. (2) Very rare cases of development of obsessive-compulsive disorders (OCD) in patients with underlying history of OCD or psychiatric disorders have been observed in post-marketing surveillance. (3) Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-01T12:51:00Z · SHA-256 0c9c2dbe2cf9e6cd5c8f5c1f489027f4a1e9204a5531ad8b866e3bc0e64b2e72 · Passage 8eb1d0829c826ca6f9a6c55b87187042301af69801d6622db707746c42972602 · Zeichen 6518–7905 im Abschnitt